Cytokinetics presented study results at the European Society of Cardiology Congress in Madrid, Spain.
6 reports, 5 independent
Updated Jul 7
Gone quiet
Reached 4 outlets in its first 24 hours
- Reports
- 6
- Developments
- 1
- Repetition
- 83%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cytokinetics presented study results at the European Society of Cardiology Congress in Madrid, Spain.
Who's involved
What this event is mainly aboutKeep exploring
Part of
The European Society of Cardiology Congress was held in Madrid, Spain.Also in this story
- Deepak L. Bhatt discussed REDUCE-IT data at the ESC Congress 2025, which was held in Madrid, Spain.
- Tenaya Therapeutics presented interim data from the MyClimb study at the European Society of Cardiology Congress.
The entities involved
-
Cytokinetics
company in South San Francisco, United States
-
Spain
country in southwestern Europe with territories in Africa
Coverage
Newest first; wire copies grouped- manilatimes.net
- ZacksCytokinetics Gains on Positive Late-Stage Cardiomyopathy Study Results Cytokinetics, Incorporated's (CYTK) shares surged 40.4% on Sept. 2, driven by positive results from a phase III study on cardiov
- Insider MonkeyCytokinetics (CYTK) Rockets 40.45% as Aficamten Results Promising We recently published 10 Power Stocks Crushing Wall Street — 7 at All-Time Highs. Cytokinetics, Inc. (NASDAQ:CYTK) is one of the best
- Clinical Trials ArenaESC 2025: study gives insight into OM and red cell distribution width On 30 August 2025, at the 75th European Society of Cardiology (ESC) conference held in Madrid, Spain, during an abstract session
- GlobeNewswireCytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025 Positive Results from MAPLE-HCM to be Shared in Hot Line Presentation Late Breaking
- GlobeNewswireCytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025 Hot Line Presentation of MAPLE-HCM to Elaborate on Positive Topline Results in Patie